Director Facteau Bill purchased 13,123 shares of BCDA at $1.90; cluster buy pattern with 5 other insiders in 14 days amid -67.6% YTD drawdown.
Facteau Bill, a director, purchased 13,123 shares at $1.90 on 2025-04-23, establishing an initial 13.1K-share position in BioCardia. This transaction occurs as part of a coordinated cluster pattern—5 other insiders also bought within the past 14 days—suggesting board-level alignment on valuation. However, the fundamental backdrop is severe: the company reported $0.00 revenue in the latest quarter, net income of $-1.7M over the most recent full year, and annual revenue growth of -87.8%. The stock has declined -67.6% from its 52-week high of $6.09 and trades at $1.97 currently, down -22.8% in the past 30 days. The combination of concentrated insider buying during a steep decline and deeply distressed fundamentals merits scrutiny regarding whether insiders perceive capitulation-level pricing or face undisclosed operational risks.